| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-064981 |
| cik | 897448 |
| name | AMARIN CORP PLCUK |
| sic | 2834 |
| countryba | IE |
| stprba | |
| cityba | DUBLIN 2 |
| zipba | D02 VK60 |
| bas1 | SPACES SOUTH DOCKLANDS, BLOCK C |
| bas2 | 77 SIR JOHN ROGERSON'S QUAY |
| baph | 353 1 6699 020 |
| countryma | IE |
| stprma | |
| cityma | DUBLIN 2 |
| zipma | D02 VK60 |
| mas1 | SPACES SOUTH DOCKLANDS, BLOCK C |
| mas2 | 77 SIR JOHN ROGERSON'S QUAY |
| countryinc | GB |
| stprinc | |
| ein | 000000000 |
| former | AMARIN PHARMACEUTICALS PLC |
| changed | 20000201 |
| afs | 2-ACC |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250507 |
| accepted | 2025-05-07 07:05:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | amrn-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-064981 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 4585679.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5218000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5218000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20241231 | Assets | 685349000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Cash And Cash Equivalents At Carrying Value | 121038000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Cost Direct Material | 24615000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Increase Decrease In Accrued Interest Receivable Net | -450000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Increase Decrease In Contract With Customer Liability | -401000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Net Cash Provided By Used In Investing Activities | 12064000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Operating Lease Liability Noncurrent | 7723000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Operating Lease Right Of Use Asset | 7592000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Other Liabilities Noncurrent | 11642000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Research And Development Expense | 5312000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Retained Earnings Accumulated Deficit | -1668546000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 42017000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Business Developments= Csl Seqirus; Product Or Service= License; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 5392000.0000 | USD | 1 | us-gaap/2024 | Geographical= Europe; Product Or Service= Product; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 35661000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; Product Or Service= Product; | ||
| 0000950170-25-064981 | 20231231 | Shares Outstanding | 418141295.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20241231 | Short Term Investments | 173182000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 3119637.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 9500.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 1980000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Treasury Stock Value | 66445000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Accounts Receivable Net Current | 122279000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 1216000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Amortization Of Intangible Assets | 729000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Assets | 655677000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Assets Current | 573061000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Common Stock Shares Issued | 422256900.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Earnings Per Share Diluted | -0.4900 | USD | 1 | us-gaap/2024 | Class Of Stock= American Depositary Share; | ||
| 0000950170-25-064981 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -8655000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Income Taxes Paid Net | 29000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Increase Decrease In Other Noncurrent Liabilities | 221000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Interest Income Expense Nonoperating Net | 3383000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Interest Income Expense Nonoperating Net | 2872000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Inventory Net | 166048000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Liabilities | 199173000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Liabilities | 181990000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Other Assets Noncurrent | 1174000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Other Nonoperating Income Expense | 1545000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Business Developments= Csl Seqirus; Product Or Service= License; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 5177000.0000 | USD | 1 | us-gaap/2024 | Geographical= Rest Of The World Except U S And Europe; Product Or Service= Product; | ||
| 0000950170-25-064981 | 20241231 | Revenue From Contract With Customer Excluding Assessed Tax | 40081000.0000 | USD | 4 | us-gaap/2024 | Business Developments= Edding; Product Or Service= License; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 41035000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product; | ||
| 0000950170-25-064981 | 20240331 | Share Based Compensation | 5218000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Stockholders Equity | -1684243000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 10000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20231231 | Stockholders Equity | -1586363000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-064981 | 20241231 | Stockholders Equity | 486176000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 6000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20241231 | Treasury Stock Common Shares | 10672049.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 410146000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 413422000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Other Assets Noncurrent | 1213000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Other Nonoperating Income Expense | 253000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Payments To Acquire Marketable Securities | 42936000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Stockholders Equity | 304742000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Treasury Stock Common Shares | -12477390.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20241231 | Treasury Stock Value | 65326000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 410146000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 20671000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= American Depositary Share; | ||
| 0000950170-25-064981 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 199777000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1514000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.5000 | GBP | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Common Stock Shares Outstanding | 414365189.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Earnings Per Share Basic | -0.0400 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20240331 | Earnings Per Share Diluted | -0.0200 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -13630000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Income Tax Expense Benefit | 1298000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Increase Decrease In Accounts Payable And Other Operating Liabilities | -34896000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Increase Decrease In Inventories | -6726000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Increase Decrease In Inventories | -13894000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Increase Decrease In Other Noncurrent Assets | -36000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Increase Decrease In Other Noncurrent Assets | -39000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Initial Recognition Of Operating Lease Right Of Use Asset | 81000.0000 | USD | 1 | 0000950170-25-064981 | |||
| 0000950170-25-064981 | 20250331 | Initial Recognition Of Operating Lease Right Of Use Asset | 1837000.0000 | USD | 1 | 0000950170-25-064981 | |||
| 0000950170-25-064981 | 20241231 | Liabilities And Stockholders Equity | 685349000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Net Income Loss | -9953000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-064981 | 20250331 | Operating Lease Liability Noncurrent | 7940000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 1436000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Payments To Acquire Marketable Securities | 33281000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 56519000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Business Developments= Csl Seqirus; Product Or Service= Product; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20231231 | Stockholders Equity | 302756000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20240331 | Stockholders Equity | -65188000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -1436000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20241231 | Treasury Stock Common Shares | -10672049.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 20507000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= American Depositary Share; | ||
| 0000950170-25-064981 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 410146000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 413422000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20241231 | Additional Paid In Capital | 1914750000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 62000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Proceeds From Stock Options Exercised | 10000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Stockholders Equity | -1668546000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-064981 | 20250331 | Common Stock Shares Issued | 426842579.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Common Stock Value | 308152000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Earnings Per Share Basic | -0.0200 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Earnings Per Share Basic | -0.0400 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Earnings Per Share Diluted | -0.0400 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Income Taxes Paid Net | 22000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -3476000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Liabilities Current | 162408000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Net Income Loss | -9953000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Operating Expenses | 41885000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Operating Income Loss | -16755000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Stockholders Equity | 308152000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | -1217450.0000 | shares | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20240331 | Net Cash Provided By Used In Operating Activities | -12601000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Operating Expenses | 45487000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Operating Lease Right Of Use Asset | 8363000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 1547000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Accrued Liabilities And Other Liabilities Current | 139583000.0000 | USD | 0 | 0000950170-25-064981 | |||
| 0000950170-25-064981 | 20250331 | Cash And Cash Equivalents At Carrying Value | 119524000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-064981 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.5000 | GBP | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Earnings Per Share Basic | -0.4900 | USD | 1 | us-gaap/2024 | Class Of Stock= American Depositary Share; | ||
| 0000950170-25-064981 | 20240331 | Earnings Per Share Diluted | -0.0200 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Earnings Per Share Diluted | -0.0400 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Finite Lived Intangible Assets Net | 16389000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 12577000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Inventory Net | 159490000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Inventory Noncurrent | 64740000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Research And Development Expense | 5598000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 3400000.0000 | USD | 1 | us-gaap/2024 | Business Developments= Edding; Product Or Service= Product; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 982000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Licensing And Royalty; | ||
| 0000950170-25-064981 | 20250331 | Earnings Per Share Basic | -0.7600 | USD | 1 | us-gaap/2024 | Class Of Stock= American Depositary Share; | ||
| 0000950170-25-064981 | 20250331 | Accounts Payable Current | 45661000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Additional Paid In Capital | 1916223000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Amortization Of Intangible Assets | 729000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 214469000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 121338000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Common Stock Value | 305298000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Depreciation And Amortization Excluding Amortization Of Intangible Assets | 33000.0000 | USD | 1 | 0000950170-25-064981 | |||
| 0000950170-25-064981 | 20250331 | Depreciation And Amortization Excluding Amortization Of Intangible Assets | 1000.0000 | USD | 1 | 0000950170-25-064981 | |||
| 0000950170-25-064981 | 20240331 | Earnings Per Share Basic | -0.0200 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Increase Decrease In Accounts Payable And Other Operating Liabilities | -17541000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Liabilities And Stockholders Equity | 655677000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Net Cash Provided By Used In Investing Activities | 28719000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Net Cash Provided By Used In Operating Activities | -12459000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Net Income Loss | -15697000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-064981 | 20240331 | Operating Income Loss | -13583000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Profit Loss | -15697000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Restricted Cash And Cash Equivalents At Carrying Value | 300000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Retained Earnings Accumulated Deficit | -1684243000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 48114000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; Product Or Service= Product; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 100000.0000 | USD | 1 | us-gaap/2024 | Business Developments= Biologix; Product Or Service= Product; Range= Maximum; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 40081000.0000 | USD | 1 | us-gaap/2024 | Business Developments= Edding; Product Or Service= License; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Business Developments= H L S Therapeutics Incorporation; Product Or Service= Product; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20250331 | Short Term Investments | 162263000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -2854000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20240331 | Treasury Stock Common Shares | -10534652.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20250331 | Treasury Stock Common Shares | 12477390.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 410146000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20241231 | Other Liabilities Noncurrent | 11501000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Prepaid Expense And Other Assets Current | 12552000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Profit Loss | -9953000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Restricted Cash And Cash Equivalents At Carrying Value | 300000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1900000.0000 | USD | 1 | us-gaap/2024 | Business Developments= H L S Therapeutics Incorporation; Product Or Service= Product; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1865000.0000 | USD | 1 | us-gaap/2024 | Geographical= Europe; Product Or Service= Product; | ||
| 0000950170-25-064981 | 20240331 | Selling General And Administrative Expense | 39889000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20231231 | Stockholders Equity | 552097000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20231231 | Stockholders Equity | 1899456000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20231231 | Stockholders Equity | -63752000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20240331 | Stockholders Equity | 545936000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Stockholders Equity | 305298000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Stockholders Equity | -66445000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 9500.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -1980000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 2854000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -1119000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 4000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20231231 | Treasury Stock Common Shares | -9317202.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 20671000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= American Depositary Share; | ||
| 0000950170-25-064981 | 20241231 | Accounts Payable Current | 40366000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4327000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4327000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 119824000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-064981 | 20250331 | Earnings Per Share Diluted | -0.7600 | USD | 1 | us-gaap/2024 | Class Of Stock= American Depositary Share; | ||
| 0000950170-25-064981 | 20250331 | Finite Lived Intangible Assets Net | 15660000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Gross Profit | 31904000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Income Tax Expense Benefit | 2067000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Increase Decrease In Accounts Receivable | -17757000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Increase Decrease In Other Noncurrent Liabilities | -413000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Liabilities Current | 179949000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Net Cash Provided By Used In Financing Activities | -1426000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Net Cash Provided By Used In Financing Activities | -1119000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 1119000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 55000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Property Plant And Equipment Net | 16000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Business Developments= Biologix; Product Or Service= Product; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Business Developments= Csl Seqirus; Product Or Service= Product; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Business Developments= Edding; Product Or Service= Product; Type Of Arrangement= Out Licenses Agreement; | ||
| 0000950170-25-064981 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | -18000.0000 | USD | 1 | us-gaap/2024 | Geographical= Rest Of The World Except U S And Europe; Product Or Service= Product; | ||
| 0000950170-25-064981 | 20240331 | Shares Outstanding | 421270432.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Shares Outstanding | 426842579.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20240331 | Stockholders Equity | -1596316000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-064981 | 20241231 | Stockholders Equity | 1914750000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20241231 | Stockholders Equity | -65326000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20250331 | Stockholders Equity | 1916223000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -1436000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 20507000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= American Depositary Share; | ||
| 0000950170-25-064981 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 413422000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20250331 | Accounts Receivable Net Current | 106734000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Accrued Liabilities And Other Liabilities Current | 116747000.0000 | USD | 0 | 0000950170-25-064981 | |||
| 0000950170-25-064981 | 20241231 | Assets Current | 595399000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 14692000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Common Stock Shares Outstanding | 411584851.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Cost Direct Material | 16887000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Gross Profit | 25130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Increase Decrease In Accounts Receivable | -15545000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Inventory Noncurrent | 57404000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Net Income Loss | -15697000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Prepaid Expense And Other Assets Current | 24750000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Property Plant And Equipment Net | 15000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1363000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Licensing And Royalty; | ||
| 0000950170-25-064981 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 55156000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product; | ||
| 0000950170-25-064981 | 20250331 | Selling General And Administrative Expense | 36573000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Share Based Compensation | 4327000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20241231 | Shares Outstanding | 422256900.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-064981 | 20240331 | Stockholders Equity | 1902698000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-064981 | 20250331 | Stockholders Equity | 473687000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | -1805341.0000 | shares | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0000950170-25-064981 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -1119000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-064981 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 413422000.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Cost Direct Material | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost, Direct Material | Cost of material used for good produced and service rendered. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Interest Income Expense Nonoperating Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating | Amount of interest income (expense) classified as nonoperating. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Finite Lived Intangible Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. |
| Treasury Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accrued Liabilities And Other Liabilities Current | 0000950170-25-064981 | 1 | 0 | monetary | I | C | Accrued Liabilities And Other Liabilities Current | Accrued liabilities and other liabilities current. |
| Initial Recognition Of Operating Lease Right Of Use Asset | 0000950170-25-064981 | 1 | 0 | monetary | D | C | Initial Recognition Of Operating Lease Right Of Use Asset | Initial recognition of operating lease right-of-use asset. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. | |
| Depreciation And Amortization Excluding Amortization Of Intangible Assets | 0000950170-25-064981 | 1 | 0 | monetary | D | D | Depreciation And Amortization Excluding Amortization Of Intangible Assets | Depreciation and amortization excluding amortization of intangible assets. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Other Operating Liabilities | Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Inventory Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Noncurrent | Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accrued Interest Receivable Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accrued Interest Receivable, Net | The increase (decrease) during the reporting period in the amount due from borrowers for interest payments. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Restricted Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash and Cash Equivalents, Current | Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Increase Decrease In Other Noncurrent Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Noncurrent Liabilities | Amount of increase (decrease) in noncurrent operating liabilities classified as other. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Treasury Stock Common Shares | us-gaap/2024 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-064981 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-064981 | 2 | 4 | BS | 0 | H | Restricted Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-064981 | 2 | 5 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Short-term investments | 0 |
| 0000950170-25-064981 | 2 | 6 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0000950170-25-064981 | 2 | 7 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory | 0 |
| 0000950170-25-064981 | 2 | 8 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid and other current assets | 0 |
| 0000950170-25-064981 | 2 | 9 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-064981 | 2 | 10 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property, plant and equipment, net | 0 |
| 0000950170-25-064981 | 2 | 11 | BS | 0 | H | Inventory Noncurrent | us-gaap/2024 | Long-term inventory | 0 |
| 0000950170-25-064981 | 2 | 12 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset | 0 |
| 0000950170-25-064981 | 2 | 13 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other long-term assets | 0 |
| 0000950170-25-064981 | 2 | 14 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2024 | Intangible asset, net | 0 |
| 0000950170-25-064981 | 2 | 15 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0000950170-25-064981 | 2 | 18 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-064981 | 2 | 19 | BS | 0 | H | Accrued Liabilities And Other Liabilities Current | 0000950170-25-064981 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-064981 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-064981 | 2 | 22 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Long-term operating lease liability | 0 |
| 0000950170-25-064981 | 2 | 23 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other long-term liabilities | 0 |
| 0000950170-25-064981 | 2 | 24 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-064981 | 2 | 25 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 5) | 0 |
| 0000950170-25-064981 | 2 | 27 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Ordinary Shares, GBP 0.50 par value per share, unlimited authorized; 426,842,639 shares issued, 41,365,249 shares outstanding as of March 31, 2025; 422,256,960 shares issued, 411,584,911 shares outstanding as of December 31, 2024 | 0 |
| 0000950170-25-064981 | 2 | 28 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-064981 | 2 | 29 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury stock; 12,477,390 shares as of March 31, 2025; 10,672,049 shares as of December 31, 2024 | 1 |
| 0000950170-25-064981 | 2 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-064981 | 2 | 31 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0000950170-25-064981 | 2 | 32 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 0 |
| 0000950170-25-064981 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Ordinary Shares, par value per share | 0 |
| 0000950170-25-064981 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Ordinary Shares, issued | 0 |
| 0000950170-25-064981 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ordinary Shares, outstanding | 0 |
| 0000950170-25-064981 | 3 | 5 | BS | 1 | H | Treasury Stock Common Shares | us-gaap/2024 | Treasury Stock, Shares | 0 |
| 0000950170-25-064981 | 4 | 7 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Total revenue, net | 0 |
| 0000950170-25-064981 | 4 | 8 | IS | 0 | H | Cost Direct Material | us-gaap/2024 | Less: Cost of goods sold | 0 |
| 0000950170-25-064981 | 4 | 9 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross margin | 0 |
| 0000950170-25-064981 | 4 | 11 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0000950170-25-064981 | 4 | 12 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-064981 | 4 | 13 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-064981 | 4 | 14 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0000950170-25-064981 | 4 | 15 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2024 | Interest income, net | 0 |
| 0000950170-25-064981 | 4 | 16 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income, net | 0 |
| 0000950170-25-064981 | 4 | 17 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss from operations before taxes | 0 |
| 0000950170-25-064981 | 4 | 18 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 1 |
| 0000950170-25-064981 | 4 | 19 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-064981 | 4 | 21 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic | 0 |
| 0000950170-25-064981 | 4 | 22 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted | 0 |
| 0000950170-25-064981 | 4 | 24 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic | 0 |
| 0000950170-25-064981 | 4 | 25 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted | 0 |
| 0000950170-25-064981 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0000950170-25-064981 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in shares) | 0 |
| 0000950170-25-064981 | 5 | 11 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2024 | Treasury Stock, Shares | 0 |
| 0000950170-25-064981 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options | 0 |
| 0000950170-25-064981 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options (in shares) | 0 |
| 0000950170-25-064981 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | Vesting of restricted stock units | 0 |
| 0000950170-25-064981 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | Vesting of restricted stock units (in shares) | 0 |
| 0000950170-25-064981 | 5 | 16 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-064981 | 5 | 17 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Loss for the period | 0 |
| 0000950170-25-064981 | 5 | 18 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0000950170-25-064981 | 5 | 19 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in shares) | 0 |
| 0000950170-25-064981 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-064981 | 6 | 4 | CF | 0 | H | Depreciation And Amortization Excluding Amortization Of Intangible Assets | 0000950170-25-064981 | Depreciation and amortization | 0 |
| 0000950170-25-064981 | 6 | 5 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Accretion of investments | 1 |
| 0000950170-25-064981 | 6 | 6 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-064981 | 6 | 7 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangible asset | 0 |
| 0000950170-25-064981 | 6 | 9 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable, net | 1 |
| 0000950170-25-064981 | 6 | 10 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory | 1 |
| 0000950170-25-064981 | 6 | 11 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid and other current assets | 1 |
| 0000950170-25-064981 | 6 | 12 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Other long-term assets | 1 |
| 0000950170-25-064981 | 6 | 13 | CF | 0 | H | Increase Decrease In Accrued Interest Receivable Net | us-gaap/2024 | Interest receivable | 1 |
| 0000950170-25-064981 | 6 | 14 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2024 | Deferred revenue | 0 |
| 0000950170-25-064981 | 6 | 15 | CF | 0 | H | Increase Decrease In Accounts Payable And Other Operating Liabilities | us-gaap/2024 | Accounts payable and other current liabilities | 0 |
| 0000950170-25-064981 | 6 | 16 | CF | 0 | H | Increase Decrease In Other Noncurrent Liabilities | us-gaap/2024 | Other long-term liabilities | 0 |
| 0000950170-25-064981 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-064981 | 6 | 19 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Maturities of securities | 0 |
| 0000950170-25-064981 | 6 | 20 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of securities | 1 |
| 0000950170-25-064981 | 6 | 21 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0000950170-25-064981 | 6 | 23 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of stock options | 0 |
| 0000950170-25-064981 | 6 | 24 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Taxes paid related to stock-based awards | 1 |
| 0000950170-25-064981 | 6 | 25 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash used in financing activities | 0 |
| 0000950170-25-064981 | 6 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | 0 |
| 0000950170-25-064981 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | 0 |
| 0000950170-25-064981 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | 0 |
| 0000950170-25-064981 | 6 | 31 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Income taxes | 0 |
| 0000950170-25-064981 | 6 | 33 | CF | 0 | H | Initial Recognition Of Operating Lease Right Of Use Asset | 0000950170-25-064981 | Initial recognition of operating lease right-of-use asset | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |